Overgaard RV, Hertz CL, Ingwersen SH, Navarria A, Drucker DJ
More than 70% of patients taking GLP-1 medications reported reduced alcohol cravings, a decreased desire to drink, a reduction in how much alcohol they drink per week, fewer drinks per drinking session, and reduced binge drinking compared to prior to starting treatment compared to the control group that was not taking GLP-1 medications
By reducing glucagon, semaglutide helps keep blood sugar levels lower
Conversely, people with long-standing obesity, multiple weight-loss attempts, or genetic predispositions to weight gain may find ongoing or cyclical treatment more realistic than stopping abruptly
Marafiga JR, Pasquetti MV, Calcagnotto ME